Tristel Plc (TSTL) Ordinary 1p Shares
![](https://online.hl.co.uk/img/hl/layout/security-up-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-up-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-up-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Share news, reports & tips
-
New Tristel products recommended for UK, EU certification
26 February 2024 12:18
(Sharecast News) - Infection prevention products developer Tristel announced the successful conclusion of all reviews required under the UK and European Union medical devices regulations for the approval of...
-
Tristel flags record first half, CEO to step down
19 December 2023 10:17
(Sharecast News) - Infection prevention products developer Tristel flagged a record-breaking first half in an update on Tuesday, with expected revenues of £20.7m for the six months ending 31 December.
-
Tristel profits jump as US sales kick off
16 October 2023 07:48
(Sharecast News) - AIM-listed Tristel saw profits jump by over a third in the year to 30 June after smashing its internal growth targets, and said it has started shipping products to its first customers in...
-
Director dealings: Tristel non-exec buys first shares, LSE buyback continues
26 June 2023 11:07
(Sharecast News) - On the list of director buys on Monday was Tristel, after a non-executive director spent almost £30k on shares.
-
Numis starts coverage of Tristel at 'add'
25 May 2023 14:33
(Sharecast News) - Numis started coverage of Tristel on Thursday with an 'add' rating and 390p price target.
-
Broker tips: Fevertree,Tristel
25 May 2023 08:29
(Sharecast News) - Liberum hiked its price target on Fevertree Drinks on Thursday to 1,500p from 1,000p following an update from the posh tonic maker.
-
Tristel books strong first-half as it enters North America markets
20 February 2023 11:00
(Sharecast News) - Infection prevention developer Tristel reported a 16% increase in first-half revenue on Monday, to £17.5m, driven by 21% growth in underlying revenue.
-
Tristel returning to pre-pandemic growth trajectory
12 December 2022 14:16
(Sharecast News) - Infection prevention product developer Tristel said in an update on Monday that it was returning to its "pre-pandemic growth trajectory", with first-half revenue set to top...
-
Tristel trading picks up in second half
18 July 2022 10:59
(Sharecast News) - Infection prevention product manufacturer Tristel said in a trading update on Monday that across all our geographical markets, the number of patient procedures carried out by hospitals...
-
Sales pick up for Tristel as hospitals return to more normal service
13 December 2021 12:55
(Sharecast News) - Infection prevention product manufacturer Tristel said in an update on Monday that sales in all of its geographies had "picked up well" as hospitals gradually returned to more...
-
Tristel starting to see signs of market recovery
21 July 2021 14:50
(Sharecast News) - Infection prevention products manufacturer Tristel said in a trading update on Wednesday that as the fourth quarter progressed, demand for its device-based products accelerated as hospital...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.